Hargreaves Lansdown

Anpario acquires US animal health and nutrition products business

Mon 30 September 2024 10:00 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - Animal feed additives manufacturer Anpario revealed on Monday that it had acquired US animal health and nutrition products business Bio-Vet.

Anpario said it had completed its acquisition of Bio-Vet, including the land and buildings at its production facility in Barneveld, Wisconsin, for a total net cash consideration of up to $7.3m.

The AIM-listed group stated the acquisition was in line with its strategy, creating further species diversification into the ruminant sector.

Anpario has made an initial cash consideration of $6.3m, including Bio-Vet's excess cash of $2.3m, on a debt-free basis, and will pay an additional earnout consideration of up to $1.0m in cash subject to the underlying earnings for the 12 months following completion coming to at least $780,000.

Chief executive Richard Edwards said: "We are delighted to have acquired Bio-Vet, which is in line with our strategy of species diversification and bringing significant new product groups to the portfolio, which can be marketed through our global sales and distribution network. The deal also gives us an excellent production facility which makes us operationally more resilient and acts as a strong platform to support growth in the Americas region."

As of 1000 BST, Vodafone shares were down 0.29% at 75.40p.

Reporting by Iain Gilbert at Sharecast.com

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.


    More AIM news from ShareCast

    No results were found